Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1979 May;24(2):357–362. doi: 10.1128/iai.24.2.357-362.1979

Regression of a transplanted guinea pig hepatoma after intralesional injection of an emulsified mixture of endotoxin and mycobacterial sulfolipid.

E Yarkoni, M B Goren, H J Rapp
PMCID: PMC414309  PMID: 378852

Abstract

Mycobacterial sulfatides (sulfolipids) in admixture with endotoxin had tumor regressive activity comparable to trehalose-6,6'-dimycolate (TDM) and endotoxin in guinea pigs, but unlike TDM were neither toxic nor granulomagenic and had no antitumor activity in mice. The increased endotoxin lethality in mice pretreated with BCG was not observed in mice pretreated with sulfolipids or TDM instead of BCG.

Full text

PDF
357

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLOCH H., DEFAYE J., LEDERER E., NOLL H. Constituents of a toxic-lipid obtained from Mycobacterium tuberculosis. Biochim Biophys Acta. 1957 Feb;23(2):312–321. doi: 10.1016/0006-3002(57)90333-5. [DOI] [PubMed] [Google Scholar]
  2. Bartlett G. L., Zbar B., Rapp H. J. Suppression of murine tumor growth by immune reaction to the Bacillus Calmette-Guérin strain of Mycobacterium bovis. J Natl Cancer Inst. 1972 Jan;48(1):245–257. [PubMed] [Google Scholar]
  3. Bekierkunst A. Acute granulomatous response produced in mice by trehalose-6,6-dimycolate. J Bacteriol. 1968 Oct;96(4):958–961. doi: 10.1128/jb.96.4.958-961.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bekierkunst A., Levij I. S., Yarkoni E. Suppression of urethan-induced lung adenomas in mice treated with trehalose-6,6-dimycolate (cord factor) and living bacillus Calmette Guérin. Science. 1971 Dec 17;174(4015):1240–1242. doi: 10.1126/science.174.4015.1240. [DOI] [PubMed] [Google Scholar]
  5. Bekierkunst A., Yarkoni E., Flechner I., Morecki S., Vilkas E., Lederer E. Immune response to sheep red blood cells in mice pretreated with mycobacterial fractions. Infect Immun. 1971 Sep;4(3):256–263. doi: 10.1128/iai.4.3.256-263.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Goren M. B., Brokl O., Das B. C. Sulfatides of Mycobacterium tuberculosis: the structure of the principal sulfatide (SL-I). Biochemistry. 1976 Jun 29;15(13):2728–2735. doi: 10.1021/bi00658a003. [DOI] [PubMed] [Google Scholar]
  7. Granger D. L., Yamamoto K. I., Ribi E. Delayed hypersensitivity and granulomatous response after immunization with protein antigens associated with a mycobacterial glycolipid and oil droplets. J Immunol. 1976 Feb;116(2):482–488. [PubMed] [Google Scholar]
  8. Kato M., Goren M. B. Synergistic action of cord factor and mycobacterial sulfatides on mitochondria. Infect Immun. 1974 Oct;10(4):733–741. doi: 10.1128/iai.10.4.733-741.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Meyer T. J., Ribi E., Azuma I. Biologically active components from mycobacterial cell walls. V. Granuloma formation in mouse lungs and guinea pig skin. Cell Immunol. 1975 Mar;16(1):11–24. doi: 10.1016/0008-8749(75)90181-1. [DOI] [PubMed] [Google Scholar]
  10. Parant M., Audibert F., Parant F., Chedid L., Soler E., Polonsky J., Lederer E. Nonspecific immunostimulant activities of synthetic trehalose-6,6'-diesters (lower homologs of cord factor). Infect Immun. 1978 Apr;20(1):12–19. doi: 10.1128/iai.20.1.12-19.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Parant M., Parant F., Chedid L., Drapier J. C., Petit J. F., Wietzerbin J., Lederer Enhancement of nonspecific immunity to bacterial infection by cord factor (6,6'-trehalose dimycolate). J Infect Dis. 1977 May;135(5):771–777. doi: 10.1093/infdis/135.5.771. [DOI] [PubMed] [Google Scholar]
  12. Rapp H. J. A guinea pig model for tumor immunology. A summary. Isr J Med Sci. 1973 Mar;9(3):366–374. [PubMed] [Google Scholar]
  13. SUTER E., KIRSANOW E. M. Hyperreactivity to endotoxin in mice infected with mycobacteria. Induction and elicitation of the reactions. Immunology. 1961 Oct;4:354–365. [PMC free article] [PubMed] [Google Scholar]
  14. Saito R., Tanaka A., Sugiyama K., Azuma I., Yamamura Y. Adjuvant effect of cord factor, a mycobacterial lipid. Infect Immun. 1976 Mar;13(3):776–781. doi: 10.1128/iai.13.3.776-781.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Yarkoni E., Meltzer M. S., Rapp H. J. Failure of trehalose-6,6'-dimycolate (P3 or cord factor) to enhance endotoxin lethality in mice. Infect Immun. 1976 Dec;14(6):1375–1377. doi: 10.1128/iai.14.6.1375-1377.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Yarkoni E., Meltzer M. S., Rapp H. J. Tumor regression after intralesional injection of emulsified trehalose-6,6'-dimycolate (cord factor): efficacy increases with oil concentration. Int J Cancer. 1977 Jun 15;19(6):818–821. doi: 10.1002/ijc.2910190612. [DOI] [PubMed] [Google Scholar]
  17. Yarkoni E., Rapp H. J. Granuloma formation in lungs of mice after intravenous administration of emulsified trehalose-6,6'-dimycolate (cord factor): reaction intensity depends on size distribution of the oil droplets. Infect Immun. 1977 Nov;18(2):552–554. doi: 10.1128/iai.18.2.552-554.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Yarkoni E., Rapp H. J., Polonsky J., Lederer E. Immunotherapy with an intralesionally administered synthetic cord factor analogue. Int J Cancer. 1978 Nov 15;22(5):564–569. doi: 10.1002/ijc.2910220510. [DOI] [PubMed] [Google Scholar]
  19. Yarkoni E., Rapp H. J. Toxicity of emulsified trehalose-6,6'-dimycolate (cord factor) in mice depends on size distribution of mineral oil droplets. Infect Immun. 1978 Jun;20(3):856–860. doi: 10.1128/iai.20.3.856-860.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES